Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecobalamin in Promoting Recurrent Laryngeal Nerve Function Recovery After Thyroid Surgery
NCT07274696Phase 3Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of mecobalamin in laryngeal nerve injury (RLNI), sponsored by West China Hospital of Sichuan University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
mecobalamin
03
Conditions
laryngeal nerve injury (RLNI)
Beyond the preview
Go deeper on NCT07274696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07274696.